Regeneron & Sanofi Get FDA’s Green Light for Dupixent
- ByTipRanks-
Co-developed by Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NASDAQ: SNY), Dupixent has bagged the U.S. Food and Drug Administration’s approval to treat eosinophilic...